close
Breaking news

A new line of argument has already come to dominate the public sphere: it’...read more The government has gone one step further to detect community spread of the coro...read more The government has issued an order to abolish the six allowances, including the...read more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected pe...read more SEOUL| South Korea’s unemployment rate was unchanged in April as the coronavi...read more Amid the outbreak of Corona pandemic in the country, Indian government has been...read more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated ...read more Corona infection in the country is taking a macabre form. So far, more than 74 ...read more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP Chi...read more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh cror...read more

First Corona Vaccine Human Trial in Russia Gets Success

Corona Vaccine

Successful testing of the world’s first corona vaccine was completed on Sunday (July 13) at Russia‘s Sechinov University. The director of the Institute of Translational Medicine and Biotechnology Vutim Tarasov said that the first group of those who have been tested for this vaccine will be discharged from the hospital on Wednesday (July 15) and the second group on July 20.

Sechenov University has successfully completed the world’s first corona virus vaccine trial on volunteers,” he said. Clinical trials of the vaccine, developed by Russia’s ‘The Gamley Institute of Epidemiology and Microbiology’, began on 18 June

Alexander Lukashev, director of the Institute of Medical Sciences, Tropical and Infectious Diseases at the University of Sechinov, said that the purpose of the trial is to find out if this vaccine is safe for human health and has been successfully completed. He said that the vaccine has been confirmed to be safe and it is as safe as the vaccines currently available in the market.

Lukashev said that a production strategy is already being set out on a further vaccine development plan, including the status of epidemiology with the virus and the possibility to produce on a large scale. Tarasov said that in the event of an epidemic, Sechinov University has not only served as an educational institution but also as a scientific and technical research center capable of participating in the manufacture of important and complex products such as drugs.

Tags: ,

Story Page

Download Our Mobile App